Upregulation of Sox2 Following Saracatinib Treatment Contributes to a Resistant Phenotype in Colorectal Cancer Cells under Growth Factor-Supplemented Conditions. - Yoon C; Na E; Choi MJ; Yoon SP (Oncology research, 2026)